Universitätsklinik für Viszerale Chirurgie und Medizin

Inselspital Bern

Die Universitätsklinik bietet einen interdisziplinären Service im Bereich der Viszeralen Chirurgie und Medizin an. Auf dem Gebiet der hochspezialisierten Medizin werden vorwiegend Patientinnen und Patienten mit Tumorleiden und anderen komplexen Baucherkrankungen betreut.

Zur Webseite des Inselspitals

Profil

  • Viszeralchirurgie – Gastroenterologie – Hepatologie
  • Abteilung für Endoskopie
  • Transplantation

Externe Partner

ETH Zurich, Systems Biology and Laboratory of Biological Engineering; Karolinska Institutet, Department of Surgery, Stockholm; University of Geneva, Molecular Biology; University of Neuchâtel, Department of Psychology; Baveno Cooperation (EASL Research Consortium); University Hospital of Bologna, Department of Internal Medicine; University of Freiburg, Germany; Crick Institute London, UK; Harvard Medical School; Institute of Immunology and Department of Pathology University of Cambridge; Kennedy Institute, University of Oxford; Department of Radiology, Jefferson University, USA; Department of Hepatology and Liver Transplantation, Mayo Clinic Rochester, USA; Liver Unit, Hospital Clinic, Barcelona, Spain; SCCS (Swiss Hepatitis C Cohort Study); ELTR (European Liver Transplant Registry); STCS (Swiss Transplant Cohort Study); LITMUS Study, DILI Registry Study (Prospective European Drug-induced liver injury Registry); ERN Rare-Liver (European Reference Network – Rare liver diseases)

Grants

  • Fondation contre le cancer, Lausanne: Pancreas Tissue Characterization by Müller Matrix Polarimetry for use in Intraoperative Diagnostics (ID) (Prof. D. Candinas, CHF 210’000)
  • SF Board grant: Towards reducing infections after healthcare-associated interventions (Prof. G. Beldi, CHF 750’000)
  • Innosuisse – Suisse Innovation Agency: Caldre: Cholestasis and liver disease resolved (Dr. F. Baier/Prof. D. Stroka, CHF 517’000)
  • SNF Starting Grant: Macrophage Aggregation Control against Scarring (MACScar) (Prof. J. Zindel, CHF 1’790’000)
  • SNF: Development of functional secretory IgA responses (Prof. A. Macpherson, CHF 1’100’000)
  • Bridge – Discovery (Prof. A. Macpherson, CHF 1’561’346)
  • SNF Sinergia: Understanding the role of immunometabolic imprinting for sustainable weight loss (Prof. Z. Al Nabhani CHF 1,261,612)
  • SNF: Role of endothelial CCL22-CCR4 axis due to increased stiffness in chronic liver disease (Prof. A. Berzgotti, CHF 763’255)
  • Gilead: SPEARHEAD (Screening imPlEmentation and linkage to cARe inHEpAtitis Delta). (Prof. N. Semmo, Prof. A. Kremer, USZ, CHF 200'000)
  • Nachwuchsförderungs-Grant der Insel Gruppe AG: Feasibility Analysis of Anti-Hexokinase 1 and Anti-Kelch-like 12 Peptide as Novel Antibodies in Primary Biliary Cholangitis. (Dr. M. Kolev, CHF 80’000)